The EB virus genome in Daudi Burkitt's lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR-1) of the virus.
about
An Epstein-Barr virus isolated from a lymphoblastoid cell line has a 16-kilobase-pair deletion which includes gp350 and the Epstein-Barr virus nuclear antigen 3AEpstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis.Antibodies against synthetic peptides react with the second Epstein-Barr virus-associated nuclear antigen.C-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7.Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cells.High-throughput RNA sequencing-based virome analysis of 50 lymphoma cell lines from the Cancer Cell Line Encyclopedia project.Epithelial cell retention of transcriptionally active, P3HR-1-derived heterogeneous Epstein-Barr virus DNA with concurrent loss of parental virus.Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cellsNucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation siteHistone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agentsInitiation of latent DNA replication in the Epstein-Barr virus genome can occur at sites other than the genetically defined originEpstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection.Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.Host cell-dependent regulation of growth transformation-associated Epstein-Barr virus antigens in somatic cell hybrids.5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line raelEpstein-Barr virus latent membrane protein: induction of B-cell activation antigens and membrane patch formation does not require vimentinExpression of the Epstein-Barr virus nuclear protein 2 in rodent cells.Amplification of Epstein-Barr virus (EBV) DNA by superinfection with a strain of EBV derived from nasopharyngeal carcinoma.A bicistronic Epstein-Barr virus mRNA encodes two nuclear proteins in latently infected, growth-transformed lymphocytesHuman neonatal lymphocytes immortalized after microinjection of Epstein-Barr virus DNAMonoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.Expression of a second Epstein-Barr virus-determined nuclear antigen in mouse cells after gene transfer with a cloned fragment of the viral genomeSensitivity of an epstein-barr virus-positive tumor line, Daudi, to alpha interferon correlates with expression of a GC-rich viral transcript.The 30-base-pair deletion in Chinese variants of the Epstein-Barr virus LMP1 gene is not the major effector of functional differences between variant LMP1 genes in human lymphocytes.Expression of two related viral early genes in Epstein-Barr virus-associated tumors.The LMP1 promoter can be transactivated directly by NF-kappaB.Induction of an exceptionally high-level, nontranslated, Epstein-Barr virus-encoded polyadenylated transcript in the Burkitt's lymphoma line Daudi.Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinoma.Dual EBNA1 promoter usage by Epstein-Barr virus in human B-cell lines expressing unique intermediate cellular phenotypes.Heterogeneity of the Epstein-Barr virus major internal repeat reveals evolutionary mechanisms of EBV and a functional defect in the prototype EBV strain B95-8.Two families of sequences in the small RNA-encoding region of Epstein-Barr virus (EBV) correlate with EBV types A and B.Truncated form of the Epstein-Barr virus protein EBNA-LP protects against caspase-dependent apoptosis by inhibiting protein phosphatase 2A.Complexities associated with expression of Epstein-Barr virus (EBV) lytic origins of DNA replication.Characterization of the deletion and rearrangement in the BamHI C region of the X50-7 Epstein-Barr virus genome, a mutant viral strain which exhibits constitutive BamHI W promoter activity.Epstein-Barr virus latency type and spontaneous reactivation predict lytic induction levels.An Epstein-Barr virus immortalization associated gene segment interferes specifically with the IFN-induced anti-proliferative response in human B-lymphoid cell lines.The EBNA2-related resistance towards alpha interferon (IFN-alpha) in Burkitt's lymphoma cells effects induction of IFN-induced genes but not the activation of transcription factor ISGF-3.
P2860
Q33854424-A96940D3-98D0-4954-8F41-CEB8C454DA6FQ33911843-142AF413-693B-4F24-9CEB-759794BAF3E0Q33931549-4B8A44A7-6525-44DC-B327-F7D93D6BAF32Q33998709-9386C0D9-CF36-400D-89E0-4330B5B1A25CQ34161866-FA7604AF-F9BB-4B43-88BB-5FB1137F07D8Q34992696-B8D1053A-8C80-46D8-AF60-F25562A15ECBQ35140295-A716C950-B660-4D79-9E64-0F08D895F7B5Q35593639-2D3F4BC6-4265-4670-8681-F02C1572AF86Q35616566-A2DAA7E6-5936-4602-A2FC-488DE41A1264Q35733719-44365824-C59B-4332-9DC4-8455FBACF57BQ36551194-AFA3F279-777D-4081-9DFD-AE4400F20184Q36782491-B8A0D3EE-4316-4722-85EE-3A622DD814F0Q36791391-3C02FF3C-2E2D-4F1E-A2A1-08C3DF75CAAAQ36793368-77672146-7400-46F8-BBA0-DF4663FDB52FQ36806063-EBF93065-C11D-44A9-AF3D-9440BAEA9D8EQ36810617-931D6B87-8AAD-44DC-83A9-8021FC4EB12FQ36828590-4B32CFE9-D544-4794-AB94-0D311E915ADEQ36829470-B99965D1-CBEB-4883-8618-A2BCC3169F2EQ36830748-D81AACDC-D534-47FA-A841-602599A01101Q36865083-A85FF13B-328A-45BF-96DF-2875B902F274Q36872412-7AE3C472-F4C8-494E-BE59-D8C75C83CBE2Q36886069-ECCAC3C3-D5DA-43EC-AC82-24486545FDE9Q36887656-C8DBA4A6-BDE2-40EF-AFAF-5DC536AF6FB1Q36920279-8011726E-E3F2-46FC-9B07-17B267298AD9Q37688813-CA07D006-C324-4E73-B7D2-BCB3967C0E43Q39448377-12E9F6F4-098A-44E4-9B89-01C48386869AQ39578471-777C9545-0213-40EA-AFC1-AA9F7ADEB026Q39589909-F7770F93-1CFF-4EF9-822F-E4118468F52DQ39874197-89C99E9F-00F4-4291-BA71-2658649EC878Q39877559-85565FE4-3829-4527-9319-7915094A2019Q39952661-3E86835C-5564-4B8A-A2D2-DB22348CF9D9Q40041854-42644DA6-C67B-4685-B8BC-0C31ACA57FD8Q40042378-B3DE0D01-9738-4916-8BCA-640299A1487BQ40100585-03E872C2-0FF5-4AD7-AFF7-F002F8785976Q40134384-112A9F71-DFCF-4359-AAA8-E38935A0D33DQ40137307-468182C6-D331-4493-B0D5-745BAEAD1B8EQ40309345-8DCD510B-A56C-4510-8059-743043FF28C2Q40793262-B16509CB-DE77-44D5-8092-88CD777F24A8Q41200381-0FF21A9A-653F-4313-AA67-9227DCC004F0Q42008273-FDE8C79D-236B-4BB2-9A8A-62873BFFBDFB
P2860
The EB virus genome in Daudi Burkitt's lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR-1) of the virus.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
The EB virus genome in Daudi B ...... strain (P3HR-1) of the virus.
@en
type
label
The EB virus genome in Daudi B ...... strain (P3HR-1) of the virus.
@en
prefLabel
The EB virus genome in Daudi B ...... strain (P3HR-1) of the virus.
@en
P2093
P2860
P1433
P1476
The EB virus genome in Daudi B ...... g strain (P3HR-1) of the virus
@en
P2093
P2860
P304
P356
10.1002/J.1460-2075.1984.TB01890.X
P407
P577
1984-04-01T00:00:00Z